This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Johnston, A. Articles by Turner, P. Search for Related Content PubMed Articles by Johnston, A. Articles by Turner, P. Social Bookmarking                         What's this?

A Study of the Interaction between Oxytetracycline and Pyridostigmine

Department of Clinical Pharmacology, St. Bartholomew's Hospital, London EC1A 7BE, UK

A. Hedges

Department of Clinical Pharmacology, St. Bartholomew's Hospital, London EC1A 7BE, UK

P. Turner

Department of Clinical Pharmacology, St. Bartholomew's Hospital, London EC1A 7BE, UK

1 Oxytetracycline and pyridostigmine were given alone and in combination for 4 days to 12 normal male volunteers in a double-blind, randomised cross-over study. On the fifth day, the pharmacokinetic profiles of the two drugs were examined, and blood and plasma cholinesterase activity was measured.

2 No significant interaction on absorption or pharmacokinetics of either drugs was detected when they were given in combination.

3 There was a small but statistically significant increase in erythrocyte cholinesterase when oxytetracycline was given in combination with pyridostigmine, the pharmacological significance of which is not clear.

Human & Experimental Toxicology, Vol. 7, No. 3, 263-266 (1988)
DOI: 10.1177/096032718800700306


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?